Tag: CorMedix
December 5, 2017
CorMedix Confirms Study Data to be Published on European Journal
CorMedix announced the acceptance of the final results of their observational post-marketing study of Neutrolin for publication in the peer-reviewed... September 12, 2017
CorMedix Will Be Part of Panel at Biotech Conference
CorMedix announced its chief scientific officer Dr. Antony Pfaffle will present at an upcoming biotech conference. August 17, 2017
CorMedix Earns Grant Award from NIH
CorMedix secured a research grant from the National Institutes of Health to expand the Company's antimicrobial hydrogel medical device program. August 2, 2017
CorMedix Gives Update on Phase 3 Clinical Program for Neutrolin
CorMedix shared an update to shareholders on their phase 3 clinical program for Neutrolin regarding a favorable correspondence with the... July 12, 2017
CorMedix Gives Update on Pipeline of Programs
CorMedix provided an update on its pre-clinical and clinical development programs to shareholders. June 12, 2017
CorMedix Announces Changes to Board of Directors
CorMedix announced changes to its board of directors in the upcoming weeks. May 9, 2017